Tag: Respirion Pharmaceuticals
Partnership between WA, Brandon BioCatalyst set to continue
The Western Australian government announced an additional $2.31 million for a further seven years, or until 2029, to continue its support for life science investment fund Brandon BioCatalyst, to which it has given $2.52 million since 2008.
Featured Article
Data-rich or data-poor: Where should manufacturers focus their AI efforts?
Over the past year, manufacturers worldwide have made significant strides in adopting artificial intelligence technologies, moving beyond the initial hype to tangible implementations that deliver real business value.
